²»Á¼Ñо¿Ëù

Bi/ond and ²»Á¼Ñо¿Ëù collaboration offers a significant advancement for DMD research and drug discovery.

²»Á¼Ñо¿Ëù will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and ²»Á¼Ñо¿Ëù Founde...

²»Á¼Ñо¿Ëù featured as one of Europe's fastest-growing startups in Sifted.

²»Á¼Ñо¿Ëù selected to join the ‘Future Fifty’ 2024 cohort as one of the UK’s most exciting technology companies.

²»Á¼Ñо¿Ëù's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to indiv...

²»Á¼Ñо¿Ëù announce first project in multi-year collaboration agreement with The Michael J. Fox Foundation to generate products for r...

²»Á¼Ñо¿Ëù's CEO, our cell programming approach and our products prominently covered in synthetic biology article.

Ginkgo Technology Network brings together over 25 partners across an array of capabilities including AI, genetic medicines, biolog...